Duearity is a Swedish medical technology company based in
Malmö. The company specialises in hardware and software for tinnitus treatment. As of May 2021, Duearity is a public company listed on the
Nasdaq First North
Nasdaq First North Growth Market is a division of Nasdaq Nordic and an alternative stock exchange (legally a multilateral trading facility) for smaller companies in Europe. The market place Nya Marknaden in Stockholm changed name to First North in ...
stock exchange.
[Nasdaq]
Listing of Duearity AB (publ), on Nasdaq First North Growth Market (203/21) , Nasdaq
accessdate: 6 december 2022[Hörselbolaget Duearity till First North]
Hörselbolaget Duearity till First North
, accessdate: 6 december 2022[Affärsvärlden]
Duearity - IPO , Affärsvärlden
, accessdate: 6 december 2022
Origins
Peter Arndt, one of Duearity's founders, was undergoing tinnitus retraining therapy (TRT) and noticed the treatment to be effective, but incompatible with daily life. Tinnitus retraining therapy is based on
cognitive behavioral therapy
Cognitive behavioral therapy (CBT) is a psycho-social intervention that aims to reduce symptoms of various mental health conditions, primarily depression and anxiety disorders. CBT focuses on challenging and changing cognitive distortions (suc ...
and requires white noise to be played uninterrupted for 6-8 hours per day for 6-24 months. Wearing headphones for prolonged and uninterrupted period of time was interfering with work during daytime and with sleep during nighttime.
The founders set out to find a solution that did not require headphones and did not occupy the ear canals.
[Digital Health Technology News]
Swedish MedTech startup starts pre-sale of unique product for tinnitus treatment - Digital Health Technology News
, accessdate: 6 december 2022[MedTech Magazine]
Malmöbolag lanserar produkt för egenbehandling av tinnitus - MedTech Magazine
, accessdate: 6 december 2022 In 2020, a proof of concept was successfully completed and the company applied for a patent.
IPO
On 11 May 2021, the company's shares debuted on
Nasdaq First North
Nasdaq First North Growth Market is a division of Nasdaq Nordic and an alternative stock exchange (legally a multilateral trading facility) for smaller companies in Europe. The market place Nya Marknaden in Stockholm changed name to First North in ...
under
ticker symbol DEAR. The company was previously called Cochlearity, but the name was changed pre-IPO in order to avoid mixup with another medtech company.
[MedTech Magazine]
Cochlearity blir Duearity inför börsnotering - MedTech Magazine
, accessdate: 6 december 2022
75,3% of the IPO shares were
subscribed before the IPO offer was made public.
Duearity’s IPO was oversubscribed by 9 times.
Products and market
Duearity is focusing its products on white noise and tinnitus retraining therapy, which has been shown to be effective in a variety of research studies.
Since 2020, Duearity has been developing the world's smallest and most flexible tinnitus aid that emits white noise through
bone conduction technology.
[BioStock]
Duearity vill hjälpa personer med tinnitusbesvär - BioStock
, accessdate: 6 december 2022[Duearity ska noteras på Nasdaq First North den 11 maj]
Duearity ska noteras på Nasdaq First North den 11 maj
, accessdate: 6 december 2022 It is a patented medtech
CE class IIa product.
[Svensk Patentdatabas, Träfflista]
Svensk Patentdatabas, Träfflista
, accessdate: 6 december 2022[PRV avser att godkänna Duearitys patentansökan]
PRV avser att godkänna Duearitys patentansökan
, accessdate: 6 december 2022 It is a non-invasive device that attaches behind the ears and keeps the ear canals free. The device will be launched in Europe once it receives a
CE marking[Duearitys produkt beräknas erhålla CE-märkning i november i år]
Duearitys produkt beräknas erhålla CE-märkning i november i år
, accessdate: 6 december 2022 and in the USA once it receives
FDA approval.
[Investeringsmemorandum-Duearity-AB-2022.pdf]
investerarmemorandum.indd - Investeringsmemorandum-Duearity-AB-2022.pdf
, accessdate: 6 december 2022
Duearity is also developing a patented software solution for analysing tinnitus and managing its symptoms.
The company observes strong interest in the solution from
researchers,
audiologists and
otorhinolaryngologists
Otorhinolaryngology ( , abbreviated ORL and also known as otolaryngology, otolaryngology–head and neck surgery (ORL–H&N or OHNS), or ear, nose, and throat (ENT)) is a surgical subspeciality within medicine that deals with the surgical a ...
.
As of 2022, it is not yet available on the market.
[Inderes: Osakeanalyysit, mallisalkku, osakevertailu & aamukatsaus]
Duearity to develop AI solution for people suffering from tinnitus , Inderes: Osakeanalyysit, mallisalkku, osakevertailu & aamukatsaus
, accessdate: 6 december 2022
References
External links
Official website*
*
{{Finance links
, name = Duearity AB
, symbol = DEAR
, bloomberg = DEAR:SS
, yahoo = DEAR.ST
, google = DEAR:STO
Further reading
Clinical research on Tinnitus retraining therapyLatest annual report (2021)IPO prospectus (2021)Patent application SE 2030236 A1
See also
*
Zwicker tone
*
Tinnitus
*
Hearing aid
*
Tinnitus masker
*
List of people with tinnitus
This is a list of notable people that have been diagnosed with tinnitus.
* Ryan Adams
* Richard Attenborough
* Igor Balis
* Thomas Bangalter
* Jeff Beck
* Ludwig van Beethoven
* Peter Brown
* Dolly Buster
* Bilinda Butcher
* Gerard Butler
* ...
Companies listed on Nasdaq Nordic
Companies listed on Nasdaq Stockholm
Medical device manufacturers
Medical and health organizations based in Sweden
Medical technology companies of Sweden
Medical equipment
Hearing aid manufacturers
Companies based in Malmö
Organizations based in Malmö
Organizations based in Sweden
Swedish brands